Geri Dön

Comparative study of different vaccine platforms for therapeutic vaccination in cancer

Başlık çevirisi mevcut değil.

  1. Tez No: 852469
  2. Yazar: YUSUF EMRE ERTEM
  3. Danışmanlar: DR. SONJA (S.I) BUSCHOW
  4. Tez Türü: Yüksek Lisans
  5. Konular: Gastroenteroloji, Gastroenterology
  6. Anahtar Kelimeler: Belirtilmemiş.
  7. Yıl: 2022
  8. Dil: İngilizce
  9. Üniversite: Erasmus Universiteit Rotterdam
  10. Enstitü: Yurtdışı Enstitü
  11. Ana Bilim Dalı: Belirtilmemiş.
  12. Bilim Dalı: Belirtilmemiş.
  13. Sayfa Sayısı: 54

Özet

Antigen presentation is one of the cornerstones of our immune system. It is often discussed in terms of fighting against infectious diseases. However, its role in cancer should not be overlooked. The current thought is that tumor cells can be seen as“non-self”since they express antigens that are not seen in healthy cells. However, hurdles created by the tumor cells, such as alterations in antigen presentation, lead to immune evasion of cancer. Therapeutic cancer vaccines aim to feed selected antigens to dendritic cells (DCs) to activate cellular immunity against that particular Tumor Associated Antigen (TAA), which is produced by the tumor cells, and then allow the elimination of the target cells, expressing that antigen. Potential platforms to be used for therapeutic vaccination include, amongst others: whole tumor lysate (WTL)-based vaccines, synthetic long peptides (SLPs)-based vaccines, and mRNA-based vaccines. Until now, it has been unclear which of these vaccine platforms yields the best anti-tumor response. In this study, we used genetically engineered HAP1 cell lines in order to test the aforementioned WTL efficiency in terms of the resulting vaccine antigen immunopeptidome to mimic the peptide repertoire on DCs. To identify Survivin, as a prototype TAA, immunopeptidome in the endogenous model, mass spectrometry-based approach was applied to the model cell line HAP1 which the HLA gene is knocked out, but HLA-A2 and Survivin gene is inserted. To test WTL vaccination, HAP1 cells without any HLA but overexpressing Survivin, were cultured, lysed, and fed to monocyte-derived dendritic cells (moDCs). This approach allowed us to compare antigen presentation and resulting immunopeptidome of the tumor situation to that antigen-fed moDC-based repertoire. However, the exogenous immune repertoire has yet to be obtained. This study, for now, served as a potential pipeline to study different vaccine platforms in terms of their immunopeptidomics in the future. KEYWORDS: Therapeutic vaccination, whole tumor lysate, moDC, HAP1, immunopeptidomics, Survivin, antigen presentation

Özet (Çeviri)

Özet çevirisi mevcut değil.

Benzer Tezler

  1. Antijenliği artırmaya yönelik yeni yaklaşımlar

    Başlık çevirisi yok

    FATIMA YÜCEL

    Doktora

    Türkçe

    Türkçe

    1997

    Tıbbi BiyolojiMarmara Üniversitesi

    Tıbbi Biyoloji Ana Bilim Dalı

    PROF. DR. BEYAZIT ÇIRAKOĞLU

  2. Kedilerin (feline) calicivirus enfeksiyonunun moleküler epidemiyolojisinin araştırılması

    Investigation of the molecular epidemiology of feline calicivirus infection

    GÜLİZAR ACAR

    Doktora

    Türkçe

    Türkçe

    2023

    Veteriner HekimliğiAnkara Üniversitesi

    Veterinerlik Viroloji Ana Bilim Dalı

    PROF. DR. SEVAL BİLGE DAĞALP

  3. Peptit yüklü nano aşı formülasyonunun toksoplazma gondii'ye karşı etkinliğinin ın vivo olarak incelenmesi

    Peptide loaded nano vaccine formulation and in vivo examination of efficiency against toxoplasma gondii

    ZEYNEP KAYA

    Yüksek Lisans

    Türkçe

    Türkçe

    2017

    BiyomühendislikYıldız Teknik Üniversitesi

    Biyomühendislik Ana Bilim Dalı

    DOÇ. DR. RABİA ÇAKIR KOÇ

  4. Sınovac aşısı uygulanan sağlık çalışanlarında aşı sonrası antikor düzeyinin belirlenmesi

    Determination of post vaccination antibody levels in HEALTH workers administered with sinovac vaccine

    KARDELEN BÜLBÜL

    Yüksek Lisans

    Türkçe

    Türkçe

    2022

    MikrobiyolojiMersin Üniversitesi

    Tıbbi Mikrobiyoloji Ana Bilim Dalı

    PROF. DR. GÖNÜL ASLAN

  5. Aşı geliştirilmesinde kullanılmak üzere çeşitli yöntemlerle elde edilen L. infantum antijenlerinin in vivo oluşturduğu immün yanıtın karşılaştırmalı olarak incelenmesi

    Comparative investigation of in vivo immune response induced by various L. infantum antigens, obtained that are with different techniques, for vaccine development

    ÖZLEM AYŞE ÖZYILMAZ

    Yüksek Lisans

    Türkçe

    Türkçe

    2014

    BiyomühendislikYıldız Teknik Üniversitesi

    Biyomühendislik Ana Bilim Dalı

    YRD. DOÇ. DR. MELAHAT BAĞIROVA